Canada markets closed

AXSM Sep 2024 95.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
2.00000.0000 (0.00%)
As of 10:26AM EDT. Market open.
Full screen
Previous Close2.0000
Open2.0000
Bid1.1500
Ask2.0000
Strike95.00
Expire Date2024-09-20
Day's Range2.0000 - 2.0000
Contract RangeN/A
Volume1
Open Interest179
  • GlobeNewswire

    Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month

    NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced today it is joining the migraine advocacy community to raise awareness of unmet patient needs during Migraine & Headache Awareness Month this June. “Education plays a crucial role in addressing the stigma associated with migraine, a complex neurological disorder often mis

  • GlobeNewswire

    Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month

    NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced today it is supporting Alzheimer’s & Brain Awareness Month this June, to help increase awareness and understanding of the challenges Alzheimer’s disease (AD) presents to patients, their caregivers, and their loved ones, and the importance of brain and mental health as cor

  • GlobeNewswire

    Axsome Therapeutics to Participate in Upcoming Investor Conferences

    NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Axsome will participate in two upcoming investor conferences. The conference details are as follows: William Blair 44th Annual Growth Stock Conference, on Wednesday, June 5, at 2 p.m. Central Time. Herriot Tabuteau, MD, Axsome’s Chief Executive Officer, will pre